TGFB1 and relapsing-remitting multiple sclerosis: Interestingly, in accordance with the miR-17 upregulation in untreated RRMS patients, we found significant downregulation of TGFBR2 mRNA, suggesting miR-17 dependent regulation of the TGFβ pathway.